ATE240956T1 - Haloalkoxy-imidazonaphthyridine - Google Patents

Haloalkoxy-imidazonaphthyridine

Info

Publication number
ATE240956T1
ATE240956T1 AT00918882T AT00918882T ATE240956T1 AT E240956 T1 ATE240956 T1 AT E240956T1 AT 00918882 T AT00918882 T AT 00918882T AT 00918882 T AT00918882 T AT 00918882T AT E240956 T1 ATE240956 T1 AT E240956T1
Authority
AT
Austria
Prior art keywords
imidazonaphthyridines
haloalkoxy
compounds
useful
preventing
Prior art date
Application number
AT00918882T
Other languages
German (de)
English (en)
Inventor
Gerhard Grundler
Wolfgang-Alexander Simon
Stefan Postius
Wolfgang Kromer
Joerg Senn-Bilfinger
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Application granted granted Critical
Publication of ATE240956T1 publication Critical patent/ATE240956T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Electroluminescent Light Sources (AREA)
  • Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT00918882T 1999-04-17 2000-04-14 Haloalkoxy-imidazonaphthyridine ATE240956T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99107688 1999-04-17
PCT/EP2000/003388 WO2000063211A1 (en) 1999-04-17 2000-04-14 Haloalkoxy imidazonaphthyridines

Publications (1)

Publication Number Publication Date
ATE240956T1 true ATE240956T1 (de) 2003-06-15

Family

ID=8237986

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00918882T ATE240956T1 (de) 1999-04-17 2000-04-14 Haloalkoxy-imidazonaphthyridine

Country Status (12)

Country Link
US (1) US6503923B1 (https=)
EP (1) EP1173439B1 (https=)
JP (1) JP2002542248A (https=)
AT (1) ATE240956T1 (https=)
AU (1) AU3966600A (https=)
CA (1) CA2370231A1 (https=)
DE (1) DE60002855T2 (https=)
DK (1) DK1173439T3 (https=)
ES (1) ES2199810T3 (https=)
PT (1) PT1173439E (https=)
SI (1) SI1173439T1 (https=)
WO (1) WO2000063211A1 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL360412A1 (en) 2000-10-25 2004-09-06 Altana Pharma Ag Polysubstituted imidazopyridines as gastric secretion inhibitors
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
EP1370261A2 (en) * 2001-03-08 2003-12-17 AstraZeneca AB New use
US6927292B2 (en) 2001-08-02 2005-08-09 Altana Pharma Ag Tricyclic epoxides
WO2003014120A1 (en) * 2001-08-03 2003-02-20 Altana Pharma Ag Amino-substituted imidazopyridines for the treatment of gastrointestinal diseases
NZ531433A (en) * 2001-08-03 2005-09-30 Altana Pharma Ag Alkyl-substituted imidazopyridines for the treatment of gastrointestinal disorders
HRP20040834A2 (en) 2002-02-15 2005-06-30 Altana Pharma Ag Tricyclic n-acyl compounds
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
CA2506027A1 (en) 2002-11-19 2004-06-03 Altana Pharma Ag 8-substituted imidazopyridines
BRPI0407541A (pt) * 2003-02-17 2006-02-14 Altana Pharma Ag combinações e uso de compostos farmaceuticamente ativos selecionados
PT1606261E (pt) 2003-03-10 2010-01-11 Nycomed Gmbh Novo processo para a preparação de roflumilast
JP2006528231A (ja) * 2003-05-27 2006-12-14 アルタナ　ファルマ　アクチエンゲゼルシャフト プロトンポンプ阻害剤と胃腸運動性を変更する化合物との医薬品組合せ物
EP1682133A1 (en) 2003-11-03 2006-07-26 AstraZeneca AB Imidazo 1,2-a pyridine derivatives for the treatment of silent gastro-esophageal reflux
AR046893A1 (es) * 2003-12-16 2005-12-28 Altana Pharma Ag Bencimidazoles triciclicos
EP1697358A1 (en) 2003-12-19 2006-09-06 Altana Pharma AG Intermediates for the preparation of tricyclic dihydropyrano -imidazo -pyridines derivatives
NZ549011A (en) * 2004-02-17 2009-04-30 Altana Pharma Ag Tricyclic imidazopyridines and intermediates for the synthesis thereof
US7931659B2 (en) * 2004-09-10 2011-04-26 Penumbra, Inc. System and method for treating ischemic stroke
WO2006037748A1 (en) * 2004-10-01 2006-04-13 Altana Pharma Ag Substituted tricyclic benzimidazoles
US8663694B2 (en) * 2005-03-16 2014-03-04 Takeda Gmbh Taste masked dosage form containing roflumilast

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468400A (en) 1982-12-20 1984-08-28 Schering Corporation Antiulcer tricyclic imidazo [1,2-a]pyridines
IL108520A (en) 1993-02-15 1997-09-30 Byk Gulden Lomberg Chem Fab 2, 3, 8-TRISUBSTITUTED IMIDAZO £1, 2-a| PYRIDINE DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
EP0971922B1 (en) * 1997-03-24 2004-04-28 ALTANA Pharma AG Tetrahydropyrido compounds
EE04677B1 (et) 1998-09-23 2006-08-15 Byk Gulden Lomberg Chemische Fabrik Gmbh Tetrahdropridoeetrid, nende kasutamine ja ravim

Also Published As

Publication number Publication date
WO2000063211A1 (en) 2000-10-26
DK1173439T3 (da) 2003-09-08
JP2002542248A (ja) 2002-12-10
EP1173439B1 (en) 2003-05-21
DE60002855T2 (de) 2004-05-06
US6503923B1 (en) 2003-01-07
AU3966600A (en) 2000-11-02
CA2370231A1 (en) 2000-10-26
SI1173439T1 (en) 2003-10-31
EP1173439A1 (en) 2002-01-23
DE60002855D1 (de) 2003-06-26
ES2199810T3 (es) 2004-03-01
PT1173439E (pt) 2003-10-31

Similar Documents

Publication Publication Date Title
DK1173439T3 (da) Halogenalkoxy-imidazonaphthyridiner
TR200201505T2 (tr) Terapötik maddeler olarak pirazolopirimidinler
LU91928I2 (fr) Ipilimumab et ses dérivés pharmaceutiquement acceptables (YERVOY®)
ATE527250T1 (de) 2,4,6-trisubstituierten pyrimidinen als phosphotidylinositol (pi) 3-kinase inhibitoren und deren verwendung zur behandlung von krebs
BR9916798A (pt) 4-arilamino, 4-arilóxi e 4-ariltio diarilaminas e seus derivados como inibidores seletivos de mek
TR200002617T2 (tr) Aril ve heteroaril sübstitüentli heterosiklik üreler kullanılarak RAF kinazın inhibe edilmesi
EE200000033A (et) Uudsed tetrasoolderivaadid
TR200401316T4 (tr) Proliferatif hastalıkları tedavi etmek için yöntemler ve bileşikler
DE60121345D1 (de) Alkylierte imidazopyridinderivate
MY121046A (en) Substituted bisindolylmaleimides for the inhibition of cell proliferation
DE60115466D1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
ATE391715T1 (de) Heterozyklische mutilinester und deren verwendung als bakterizide
TR200201128T2 (tr) PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri.
DK1268472T3 (da) 3-aminopyrazolinhibitorer af cyclinafhængige kinaser
ATE333457T1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
BR0012169A (pt) Dihidrobenzodiazepinas e seu uso no tratamento de dislipidemia
MXPA04005129A (es) Uso de diamina de acido piridin-2,4-dicarboxilico y de diaminas de acido pirimidin-4,6-dicarboxilico para la inhibicion selectiva de la colagenasa.
MY135375A (en) Pyrimidine-4,6-dicarboxylic acid diamides for selectively inhibiting collagenases
PT1000046E (pt) Derivados de piperazina activos no trato urinario inferior
TR200103858T2 (tr) Hücre yapışmasının önleyicileri olarak ikame edilmiş purin türevleri
DE60315288D1 (de) Cyanoguanidin prodrugs
ATE330958T1 (de) Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate
DK1244643T3 (da) Tryptaseinhibitorer
MXPA03000887A (es) Derivados heterociclicos fusionados como inhibidores de fosfodiesterasa.
ATE322898T1 (de) Inhibitoren von mycobakterien

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1173439

Country of ref document: EP

REN Ceased due to non-payment of the annual fee